An Act To Allow Collaborative Practice Agreements between Authorized Practitioners and Pharmacists
Maine Legislature, Session 126, LD 1134
Committee Amendment CA_A_S161 (Senate)

COMMITTEE AMENDMENT 'A " to S.P. 395, L.D. 1134, Bill, "An Act To 
Allow Collaborative Practice Agreements between Authorized Practitioners and 
Pharmacists" 
Amend the bill in section 1 in subsection 2-A in the 3rd line (page 1, line 5 in L.D.) 
by inserting after the following: "pharmacist" the following: 'as authorized by a 
practitioner' 
Amend the bill in section 4 in § 13841 in subsection 2 in paragraph D in the 2nd line 
(page 2, line 31 in L.D.) by striking out the following: "the practitioner" and inserting the 
following: 'a practitioner who is treating the patient, as long as the action is reported to 
the practitioner in a timely mamLer as determined by rules adopted pursuant to section 
13846' 
Amend the bill in section 4 in § 13842 in subsection 2 in paragraph A in the 4th line 
(page 3, line 4 in L.D.) by striking out the following: "or" and inserting the following: 'of 
Amend the bill in section 4 in § 13842 in subsection 2 in paragraph A in the last line 
(page 3, line 5 in L.D.) by stnking out the following: "the area" and inserting the 
following: 'each clinical area' 
Amend the bill in section 4 in § 13842 in subsection 2 in paragraph B in the 4th line 
(page 3, line 9 in L.D.) by striking out the following: "or" and inserting the following: 'of 
Amend the bill in section 4 in § 13842 in subsection 2 in paragraph B in the 4th line 
(page 3, line 9 in L.D.) by striking out the following: "the area" and inserting the 
following: 'each clinical area' 
. 
Amend the bill in section 4 in § 13842 in subsection 2 in paragraph C in the 4th line 
(page 3, line 14 in L.D.) by striking out the following: "or" and inserting the following: 
'of 
Amend the bill in section 4 in § 13842 in subsection 2 in paragraph C in the 4th line 
(page 3, line 14 in L.D.) by striking out the following: "the area" and inserting the 
following: 'each clinical area' 
COMMIT'TEE AMENDMENT 
COMMITTEE AMENDMENT 'A" to S.P. 395, L.D. 1134 
I 
Amend the bill in section 4 in§ 13843 in subsection I in the 2nd line (page 3, line 20 
in L.D.) by inserting after the following: "board" the following: 'and the licensing board 
that licenses the practitioner' 
Amend the bill in section 4 in § 13843 by striking out all of subsection 6 and inserting 
the following: 
'6. Contents of agreement. A practitioner and a pharmacist desiring to engage in 
collaborative practice in accordance with this subchapter shall execute a collaborative 
practice agreement that must contain, but is not limited to: 
A. 
A provision that states that activity in the initial 3 months of a collaborative 
practice agreement is limited to monitoring drug therapy. After the initial 3 months, 
the practitioner and pharmacist shall meet to review the collaborative practice 
agreement and determine the scope of the agreement, which may after the initial 3 
months include a pharmacist's initiating, monitoring, modifying and discontinuing a 
patient's drug therapy and reporting these actions to the practitioner in a timely 
manner in accordance with rules adopted pursuant to section 13846; 
B. Identification and signatures of the parties to the collaborative practice agreement, 
the dates the agreement is signed and the beginning and ending dates of the period of 
time during which the agreement is in effect; 
C. A provision that allows either party to cancel the collaborative practice agreement 
by written notification; 
D. Specification of the site and setting at which the collaborative practice will occur; 
E. Specification of the qualifications of the participants in the collaborative practice 
agreement; 
F. A detailed description of the types of diseases, drugs or drug categories involved 
and collaborative drug therapy management allowed in each patient's case; and 
G. A procedure for the referral of each patient to the practitioner.' 
Amend the bill in section 4 by striking out all of § 13846 and inserting the following: 
'§13846. Rules 
The board and the Board of Licensure in Medicine, after consultation with the 
Department of Health and Human Services, shall adopt rules to implement this 
subchapter. The rules must include rules establishing record-keeping and documentation 
procedures and reporting requirements and must allow for electronic filing when possible. 
Rules adopted pursuant to this section are routine technical rules as defined in Title 5, 
chapter 375, subchapter 2-A. 
§13847. Exemptions 
Nothing in this subchapter may be construed to limit the scope of practice of a 
pharmacist pursuant to this chapter or to apply to collaborative practice agreements 
entered into between a pharmacist and a hospital solely for the treatment of inpatients at 
the hospital.' 
COMMITTEE AMENDMENT 
COMMITTEE AMENDMENT 'A" to S.P. 395, L.D. 1134 
Amend the bill by relettering or renumbering any nonconsecutive Part letter or 
section number to read consecuti vely. 
S~ARY 
This amendment makes the f,Jllowing changes to the bill. 
1. It amends the definition of "collaborative drug therapy management" to require 
authorization by a practitioner in accordance with the collaborative practice agreement. 
2. It amends the scope of authority for pharmacists engaging in collaborative drug 
therapy management by clarifying that the agreement must be with a practitioner who is 
treating the patient and that all actions must be reported to the practitioner in a timely 
manner according to rules jointly adopted by the Maine Board of Pharmacy and the 
Board of Licensure in Medicine. 
3. It requires a pharmacist to submit a copy of the collaborative practice agreement 
to the Maine Board of Pharmacy and the board that licenses the practitioner. 
4. It requires that a collaborative practice agreement include a provision that states 
that activity in the initial 3 months of all collaborative practice agreements is limited to 
monitoring drug therapy. After the initial 3 months, the practitioner and pharmacist are 
required to meet to review the agreement and determine its scope, which may after the 
initial 3-month period include a pharmacist's initiating, monitoring, modifying and 
discontinuing a patient's drug therapy and reporting to the practitioner in a timely manner 
as determined by rule. 
5. It reGjuires the Maine Board of Pharmacy and the Board of Licensure in Medicine 
to jointly adopt rules to 
impl~:ment the subchapter on collaborative drug therapy 
management enacted by the bill. 
6. It adds an exemption to clarify that the subchapter on collaborative drug therapy 
management enacted by the bill does not limit the scope of practice of a pharmacist under 
the Maine Pharmacy Act or prohibit a pharmacist that is employed by a hospital from 
participating in a collaborative practice agreement with the hospital solely for treatment 
of inpatients. 
FisCAL ~OTE REQUIRED 
(See attached) 
COMMIT-fEE AMENDMENT 
Approved: 05/29113 
.1b?ac:.. 
LD 1134 
LR 1206(02) 
An Act To Allow Collaborative Practice Agreements between Authorized Practitioners and 
Pharmacists 
Fiscal Note for Bill as Amended by Committee Amendment '1<:(:5- r fa I ) 
Committee: Labor, Commerce, Research and Economic Development 
Fiscal Note Required: Yes 
Fiscal Note 
Minor cost increase - Other Special Revenue Funds 
Fiscal Detail and Notes 
Additional costs to the Maine Board of Pharmacy within the Office of Professional and Occupational Regulation, 
Department of Professional and Financial Regulation, and the Board of Licensure in Medicine, affiliated with the 
Department of Professional and Financial Regulation, associated with the rulemaking process can be absorbed within 
existing budgeted resources. 
LR1206(02) - Fiscal Note - Page 1 of 1